Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa
Yusuke Shimakawa(Institut Pasteur), Maud Lemoine(St Mary's Hospital), Mark Thursz(St Mary's Hospital), Jean Nana(Université Grenoble Alpes), Shevanthi Nayagam(Imperial College Healthcare NHS Trust), Umberto D’Alessandro(MRC Unit the Gambia), Isabelle Chemin(Inserm), Adam Jeng(MRC Unit the Gambia), Julie Bottero, Patrick Ingiliz, Amie Ceesay(MRC Unit the Gambia), Gerrit Post(Charité - Universitätsmedizin Berlin), Harr Freeya Njai(MRC Unit the Gambia), Philippe Bonnard(Sorbonne Université), Roger Sombié(Centre Hospitalier Universitaire Yalgado Ouédraogo), Bakary Sanneh(Ministry of Health and Social Welfare), Gibril Ndow(MRC Unit the Gambia), Vincent Leroy(Université Grenoble Alpes), Maimuna Mendy(Centre international de recherche sur le cancer), Penda Suso(Edward Francis Small Teaching Hospital), P.S. Mbaye(Hôpital Principal de Dakar), Muriel Vray(Institut Pasteur), Ramou Njie(MRC Unit the Gambia), Ignatius Baldeh(Ministry of Health and Social Welfare)
Cited by 71
Related Papers
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
|New England Journal of Medicine|2015|451
Association between an MHC Class II Allele and Clearance of Hepatitis B Virus in the Gambia
|New England Journal of Medicine|1995|439